Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy — insights from high-density, multi-electrode catheter mapping

[1] Della Bella P(2013)Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation Circulation 127 1359-1368

[2] Baratto F(2016)Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia J Am Coll Cardiol 68 1990-1998

[3] Tsiachris D(2016)Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis J Cardiovasc Electrophysiol 27 1437-1447

[4] Trevisi N(2005)Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease J Cardiovasc Electrophysiol 16 S59-70

[5] Vergara P(2000)Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy Circulation 101 1288-1296

[6] Bisceglia C(2015)Impact of electrode type on mapping of scar-related VT J Cardiovasc Electrophysiol 26 1213-1223

[7] Gokoglan Y(2020)Multielectrode mapping versus point-by-point mapping for catheter ablation of ventricular tachycardia: a systematic review and meta-analysis JACC Clinical electrophysiology 6 876-878

[8] Mohanty S(2010)Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia J Am Coll Cardiol 55 2355-2365

[9] Gianni C(2008)Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 270-276

[10] Santangeli P(2017)Significance of inducible nonsustained ventricular tachycardias after catheter ablation for ventricular tachycardia in ischemic cardiomyopathy Circ Arrhythm Electrophysiol 10 1-10

[1] Della Bella P(2013)Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation Circulation 127 1359-1368

[2] Baratto F(2016)Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia J Am Coll Cardiol 68 1990-1998

[3] Tsiachris D(2016)Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis J Cardiovasc Electrophysiol 27 1437-1447

[4] Trevisi N(2005)Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease J Cardiovasc Electrophysiol 16 S59-70

[5] Vergara P(2000)Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy Circulation 101 1288-1296

[6] Bisceglia C(2015)Impact of electrode type on mapping of scar-related VT J Cardiovasc Electrophysiol 26 1213-1223

[7] Gokoglan Y(2020)Multielectrode mapping versus point-by-point mapping for catheter ablation of ventricular tachycardia: a systematic review and meta-analysis JACC Clinical electrophysiology 6 876-878

[8] Mohanty S(2010)Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia J Am Coll Cardiol 55 2355-2365

[9] Gianni C(2008)Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 270-276

[10] Santangeli P(2017)Significance of inducible nonsustained ventricular tachycardias after catheter ablation for ventricular tachycardia in ischemic cardiomyopathy Circ Arrhythm Electrophysiol 10 1-10